Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer
Conditions
- Ovarian Cancer
- Peritoneal Cavity Cancer
Interventions
- DRUG: Docetaxel
- DRUG: Gemcitabine hydrochloride
Sponsor
Robert Morris
Collaborators